Impact of early T-bet on CD8 T cell effector responses
Impact of early T-bet on CD8 T cell effector responses
批准号:
9158586
负责人:
CHRISTOPHER A HUNTER
金额:
$40.23万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-21 至 2021-05-31
关键词:
AffectAntigensBiologicalCCL3 geneCD8B1 geneCell Adhesion MoleculesCell CommunicationCell CycleCellsCellular ImmunityCellular ImmunologyChemotactic FactorsDataDevelopmentDiseaseEventGATA3 geneGenerationsGrantHandImageImmuneImmune systemImmunologyIn VitroInfectionInflammatoryInterferonsInterleukin-12KnowledgeLaboratoriesLeadLinkMediatingMemoryModelingMusParasitesPathway interactionsPhasePhenotypePopulationPredispositionProcessProductionProliferatingPublishingReporterResearch PersonnelResistanceResistance to infectionRoleSignal TransductionSiteSystemT cell responseT-Cell ActivationT-LymphocyteTestingTimeToxoplasmaToxoplasma gondiiTranscriptional RegulationTransgenic OrganismsUp-RegulationVaccinesWorkcell behaviorcellular imagingcomparativecytokinein vivointerestintravital imaginglong term memorynovelpathogenpromoterresearch studyresponsetooltranscriptome sequencing
中文摘要
项目摘要
了解极化T细胞反应的转录调控及其与炎症的联系
在过去的20年里,条件和对感染的抵抗力一直是免疫学的一个主要主题,
导致T-bet、GATA 3和RoR β t被鉴定为Th 1、Th 2和Th 3的发展的“主调节因子”。
和Th 17型应答。因此,T-bet促进IFN-γ产生的能力已经被证实。
主导了我们对T-bet如何在感染环境中促进T细胞反应的理解。这是
T-bet-/-小鼠对各种细胞内感染的易感性增加,包括
机会寄生虫弓形虫。在CD 4+和CD 8 + T细胞中,有很好的证据表明T细胞
活化伴随着T-bet表达的两个波(T-bet两步),并且初始TCR-γ表达的两个波(T-bet两步)是T-bet表达的两个波(T-bet两步)。
T-bet介导的诱导使T细胞对由细胞因子如IL-12提供的极化信号敏感
这进一步增强了T-bet表达和分化的承诺。然而,我们最近出版的
初步研究表明,在CD 8 + T细胞中,T-bet可能在控制免疫应答中发挥意想不到的作用。
大量早期T细胞活化诱导的事件,包括粘附分子的上调,
化学引诱物和CD 8 + T细胞进入细胞周期。这些结果导致了一个新的假设
T-bet的早期诱导优化了最近激活的T和DC群体之间的相互作用,
以促进进入细胞周期、优化扩增和获得效应子功能。
为了验证这一假设,我们将结合联合收割机转录谱来鉴定T-bet的早期靶点,
本领域的细胞免疫学和成像方法来理解T-bet的作用,
初始事件中的候选者对于产生所需的效应器响应是必要的,
对细胞内病原体的抵抗力。
英文摘要
Project Summary
Understanding the transcriptional regulation of polarized T cell responses and their link to inflammatory
conditions and resistance to infection has been a major theme in immunology for the last 20 years and has
led to the identification of T-bet, GATA3 and RoRt as “master regulators” of the development of Th1, Th2
and Th17 type responses, respectively. As such, the ability of T-bet to promote IFN- production has
dominated our appreciation of how T-bet contributes to T cell responses in the setting of infection. This is
reinforced by the increased susceptibility of T-bet-/- mice to various intracellular infections, including the
opportunistic parasite Toxoplasma gondii. In CD4+ and CD8+ T cells there is good evidence that T cell
activation is accompanied by two waves of T-bet expression (the T-bet two step) and that the initial TCR-
mediated induction of T-bet sensitizes T cells for polarizing signals provided by cytokines such as IL-12
that reinforce further T-bet expression and commitment to differentiation. However, our recent published
and preliminary studies indicate that in CD8+ T cells T-bet may have an unanticipated role in controlling a
myriad of early T cell activation induced events including upregulation of adhesion molecules and
chemoattractants and entry of CD8+ T cells into cell cycle. These results have led to the novel hypothesis
that the early induction of T-bet optimizes the interactions between recently activated T and DC populations
to promote entry into the cell cycle, optimize expansion and the acquisition of effector functions.
To test this hypothesis we will combine transcriptional profiling to identify early targets of T-bet with state of
the art cellular immunology and imaging approaches to understand the role of T-bet and in hand
candidates in the initial events that are essential for the generation of effector responses required for
resistance to an intracellular pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of CD40L in resistance to enteric infection
-
批准号:10626091
-
项目类别:
-
资助金额:$98.7万
-
财政年份:2021
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
The role of CD40L in resistance to enteric infection
-
批准号:10291283
-
项目类别:
-
资助金额:$53.4万
-
财政年份:2021
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
The role of CD40L in resistance to enteric infection
-
批准号:10470882
-
项目类别:
-
资助金额:$55.27万
-
财政年份:2021
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Neuronal Latency and Toxoplasma
-
批准号:10684335
-
项目类别:
-
资助金额:$75.94万
-
财政年份:2020
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Neuronal Latency and Toxoplasma
-
批准号:10466887
-
项目类别:
-
资助金额:$75.39万
-
财政年份:2020
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Neuronal Latency and Toxoplasma
-
批准号:10810517
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2020
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Neuronal Latency and Toxoplasma
-
批准号:10793126
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2020
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Neuronal Latency and Toxoplasma
-
批准号:10268235
-
项目类别:
-
资助金额:$74.89万
-
财政年份:2020
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Immunity to Cryptosporidium
-
批准号:10529267
-
项目类别:
-
资助金额:$74.07万
-
财政年份:2019
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Immunity to Cryptosporidium
-
批准号:10063469
-
项目类别:
-
资助金额:$73.94万
-
财政年份:2019
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Immunity to Cryptosporidium
-
批准号:10306381
-
项目类别:
-
资助金额:$74.07万
-
财政年份:2019
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Impact of early T-bet on CD8 T cell effector responses
-
批准号:9301463
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2016
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Utilizing BATF3-dependent DC to generate vaccine-induced cell mediated immunity
-
批准号:9302664
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2016
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
IL-27 and Treg cells
-
批准号:8969662
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
IL-27 and Treg cells
-
批准号:9391639
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Host-parasite interactions during toxoplasmosis
-
批准号:8473630
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2013
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
IL-27 and Treg cells
-
批准号:8657334
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Host-parasite interactions during toxoplasmosis
-
批准号:8656666
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Role of chemokines in the T cell response to ocular toxoplasmosis
-
批准号:8258720
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2011
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
Role of chemokines in the T cell response to ocular toxoplasmosis
-
批准号:8034045
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2011
-
负责人:CHRISTOPHER A HUNTER
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: